Tissue Plasminogen Activator Secretion Research Articles

Polarized secretion of tissue-plasminogen activator in cultured thyroid cells

We studied the polarized secretion of tissue-type plasminogen activator in porcine thyroid cells cultured as a monolayer on porous bottom chambers. The presence of tissue-type plasminogen activator was detected by zymographic analysis on two independent media that were in contact either with the apical surface or with the basolateral membrane. The amount of tissue-type plasminogen activator was determined in both media by ELISA and enzyme assay. Measurable tissue-type plasminogen activator activity was found in the basal but not in the apical medium. However, on zymogram, a lytic zone corresponding to tissue-type plasminogen activator was visible in both media. In addition, a lytic band at 130 kDa suggested presence of a complex formed by tissue-type plasminogen activator and an inhibitor. Preferential basolateral tissue-type plasminogen activator antigen secretion (70%) has been observed, showing the possible relation between tissue-type plasminogen activator and extracellular matrix components. Neither tissue-type plasminogen activator level nor polarized secretion seemed to be regulated by thyrotropin (0.1 mU/ml).

Follicle-stimulating hormone induces functional receptors for basic fibroblast growth factor in rat granulosa cells.

In the present study we examined the existence of receptors for basic fibroblast growth factor (bFGF) and its regulation in rat granulosa cells. The binding of labeled bFGF to rat granulosa cells was dose-dependently displaced by unlabeled bFGF, but not other growth factors. FSH induced a dose-dependent increase in specific binding for bFGF to cultured rat granulosa cells. FSH treatment did not change the binding affinity (Kd, 2.8-3.0 x 10(-10) M) of the bFGF receptor, but increased the total number of bFGF-binding sites, whereas treatment with several steroid hormones had no effect on the specific binding of bFGF. Since cycloheximide, a protein synthesis inhibitor, inhibited the increase in bFGF binding induced by FSH, it is suggested that protein synthesis might be involved in the FSH stimulation of bFGF receptor induction. Furthermore, bFGF stimulated tissue plasminogen activator activity in a dose-dependent manner, and FSH-primed granulosa cells were more responsive to bFGF action, with a decrease in the ED50 from 5.0 to 1.5 ng/ml. The antibody against human bFGF neutralized the stimulatory effect of bFGF on tissue plasminogen activator secretion. The present study suggests that FSH induces functional receptors for bFGF in granulosa cells and that bFGF may play a role in the process of differentiation under the influence of FSH.

Follicle-stimulating hormone induces functional receptors for basic fibroblast growth factor in rat granulosa cells

In the present study we examined the existence of receptors for basic fibroblast growth factor (bFGF) and its regulation in rat granulosa cells. The binding of labeled bFGF to rat granulosa cells was dose-dependently displaced by unlabeled bFGF, but not other growth factors. FSH induced a dose-dependent increase in specific binding for bFGF to cultured rat granulosa cells. FSH treatment did not change the binding affinity (Kd, 2.8-3.0 x 10(-10) M) of the bFGF receptor, but increased the total number of bFGF-binding sites, whereas treatment with several steroid hormones had no effect on the specific binding of bFGF. Since cycloheximide, a protein synthesis inhibitor, inhibited the increase in bFGF binding induced by FSH, it is suggested that protein synthesis might be involved in the FSH stimulation of bFGF receptor induction. Furthermore, bFGF stimulated tissue plasminogen activator activity in a dose-dependent manner, and FSH-primed granulosa cells were more responsive to bFGF action, with a decrease in the ED50 from 5.0 to 1.5 ng/ml. The antibody against human bFGF neutralized the stimulatory effect of bFGF on tissue plasminogen activator secretion. The present study suggests that FSH induces functional receptors for bFGF in granulosa cells and that bFGF may play a role in the process of differentiation under the influence of FSH.

Calcium-regulated secretion of tissue plasminogen activator and parathyroid hormone from human parathyroid cells

Calcium-regulated secretion of tissue plasminogen activator and parathyroid hormone from human parathyroid cells

Calcium-regulated secretion of tissue plasminogen activator and parathyroid hormone from human parathyroid cells.

The effects of Ca and other agents on secretion of plasminogen activator (PA) and PTH have been examined and compared, using parathyroid cells obtained from the glands of chronic renal patients. During 2 weeks culture at different [Ca], the secretory rates of PA activity and PTH were parallel; steady-state secretion over 24-h periods was maximal at 0.5-0.9 mM Ca, minimal at 1.5-2.5 mM Ca, and the [Ca] at 50% suppression was 1.1 mM. At 2.5 mM Ca, two inhibitors of cellular proteolysis, 3-methyladenine and chloroquine, stimulated secretion of both PA activity and PTH. The results indicated that secretion of PA from human parathyroid cells is regulated similarly to that of PTH. The characteristics of human parathyroid PA were also examined using human parathyroid adenoma tissue. In homogenates, the highest specific activity of PA was in microsomal fractions. The Mr of PA from tissue and from culture media was 70 kilodalton by sodium dodecyl sulfate gel electrophoresis followed by zymography, or by Western blotting using antisera to human tissue PA (tPA). Enzyme activity was inhibited by incubation with antisera to tPA but not to urokinase. In contrast to bovine parathyroid cells that secrete a urokinase, human parathyroids apparently contain and secrete tPA.

Secretion of plasminogen activators by normal bone marrow cells and leukaemic myeloid cells

The secretion of tissue plasminogen activator (t-PA) and urokinase by normal human bone marrow cells is a differentiation linked property with t-PA being produced by primitive progenitor cells and urokinase being produced by more differentiated cells and by mature neutrophils and macrophages. Cells from patients with acute myeloid leukaemia also secrete both types of plasminogen activator (PA) and the type of enzyme secreted has prognostic significance. Patients whose cells secrete t-PA die rapidly and fail chemotherapy whereas 80% of those individuals whose cells secrete urokinase enter remission following chemotherapy. The generation of plasmin in the haemopoietic microenvironment would influence haemopoiesis by converting precursor cytokines to active species and would also release various haemopoietic cytokines from cell surfaces and matrix facilitating their interaction with cell surface receptors. The inappropriate secretion of PAs by leukaemic cells could result in abnormal haemopoiesis due to the aberrant plasmin-mediated activation and release of various cytokine species.

Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells.

F9 embryonal mouse teratocarcinoma cells were differentiated to a primitive endoderm-like phenotype by retinoic acid and to a parietal endoderm-like phenotype by retinoic acid in combination with dibutyryl cyclic AMP. The secretion of tissue plasminogen activator (tPA) is a characteristic of the cells displaying the differentiated phenotypes. The fundamental question of whether tPA secretion is regulated acutely by G-protein-mediated transmembrane signaling was explored. Cells differentiated to primitive and parietal endoderm demonstrated a rapid tPA response to stimulation by beta-adrenergic agonist (isoproterenol). Adenylyl cyclase activity in response to isoproterenol and GTP, but not forskolin, was greater in primitive and parietal endoderm than F9 stem cells. Both primitive and parietal endoderm cells, but not F9 stem cells, displayed beta-adrenergic stimulation of cyclic AMP accumulation. Retinoic acid induced F9 stem cells to the primitive endoderm phenotype and increased beta-adrenergic receptor levels 3-fold. Gi alpha 2 levels declined, G beta-subunits increased, and Gs alpha levels were unchanged following differentiation to primitive endoderm. In parietal endoderm cells beta-adrenergic receptors increased 2-fold over F9 stem cells, Gi alpha 2 levels declined even further than in primitive endoderm, G beta-subunits increased compared to F9 stem cells, and Gs alpha levels again were unchanged. The marked potentiation of short-term stimulation of tPA secretion in the differentiated state may be best explained by the retinoic acid-induced increase in expression of beta-adrenergic receptors coupled with a decline in Gi alpha 2 levels. Short-term regulation by G-protein-linked receptors represents a novel mode for the control of tPA secretion.

Phosphatidylinositol liposomes increase calcium uptake and tissue plasminogen activator secretion by fetal human lung fibroblasts

PtdIns liposomes, at a concentration of 40 microM, induced in FLF the synthesis of t-PA-Ag, and enhanced 45Ca2+ uptake. The induction of t-PA-Ag biosynthesis by PtdIns liposomes in FLF was inhibited by 5-15 microM verapamil, an inhibitor of Ca2+ uptake via the so-called "slow channels" by 0.5-10 microM TFP, an inhibitor of Ca2+ transport ATPase, and by 10-90 microM TMB-8, an inhibitor of intracellular Ca2+ mobilization. t-PA-Ag secretion was inhibited by decreasing the Ca2+ concentration less than 1.2 mM. On the other hand, addition of 0.08 microM of calcium ionophore A23187 increased t-PA-Ag biosynthesis after 72 hr of incubation by 247% (P less than 0.01). These data support previous results and indicate that the synthesis of t-PA in FLF is Ca2+ dependent. Thus, it is suggested that PtdIns liposomes increase t-PA biosynthesis by affecting calcium metabolism.

Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress

Fluid shear stress can stimulate secretion of tissue plasminogen activator (tPA) by cultured human endothelial cells, while plasminogen activator inhibitor type-1 secretion remains unstimulated. To determine whether hemodynamically induced changes in tPA messenger RNA (mRNA) levels also occur, primary cultures from the same harvest of primary human umbilical vein endothelial cells were either maintained in stationary culture or exposed to arterial levels of shear stress (25 dynes/cm2) for 24 hours. Total cellular RNA was isolated from the shear stressed and stationary cultures and the relative levels of tPA mRNA and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA were determined using a coupled reverse transcriptase/polymerase chain reaction method. As indicated by the amount of amplification product, tPA mRNA levels were many fold higher (greater than 10) in endothelial cells subjected to shear stress for 24 hours than in stationary controls. In contrast, mRNA levels for GAPDH were similar in control and shear stressed cells. The constancy of the measured GAPDH signal indicated that the tPA response was a selective effect of fluid shear stress. When a similar polymerase chain reaction method was used, the mRNA levels of basic fibroblast growth factor (bFGF) were found not to vary in comparison to GAPDH mRNA after 24 hours of shear stress. These results indicate that enhancement of the fibrinolytic potential of endothelial cells in response to hemodynamic forces could involve transcriptional events.

Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562)

The secretion of tissue plasminogen activator (t-PA), urokinase (u-PA) and their inhibitors by the human leukemia cell line K562 was examined. K562 cells normally secrete both t-PA and u-PA in a ratio of 3:1. After addition of 10 or 1 ng/mL phorbol myristate acetate (PMA) to K562 cells, a marked decrease in enzymatic activity is observed in the medium. However, when t-PA antigen rather than activity is measured, an increased amount is found in the medium under these conditions. PMA also induces secretion of the two inhibitors of plasminogen activator: plasminogen activator inhibitor 1 (PAI-1) and plasminogen activator inhibitor 2 (PAI-2). This accounts for the decrease in total enzymatic activity under conditions when production of t-PA antigen is increased. A study of the time course of induction revealed that the synthesis of plasminogen activator occurred before that of its inhibitors. Low concentrations of PMA (0.1 ng/mL) induce t-PA antigen primarily and not the inhibitors. This results in an increase in total enzymatic activity, with 94% of the secreted activity being t-PA. Thus, the secretion of plasminogen activators and their inhibitors can be manipulated in certain leukemic cells by inducers such as PMA.

Regulation and Secretion of Plasminogen Activators and Their Inhibitors in a Human Leukemic Cell Line (K562)

The secretion of tissue plasminogen activator (t-PA), urokinase (u-PA) and their inhibitors by the human leukemia cell line K562 was examined. K562 cells normally secrete both t-PA and u-PA in a ratio of 3:1. After addition of 10 or 1 ng/mL phorbol myristate acetate (PMA) to K562 cells, a marked decrease in enzymatic activity is observed in the medium. However, when t-PA antigen rather than activity is measured, an increased amount is found in the medium under these conditions. PMA also induces secretion of the two inhibitors of plasminogen activator: plasminogen activator inhibitor 1 (PAI-1) and plasminogen activator inhibitor 2 (PAI-2). This accounts for the decrease in total enzymatic activity under conditions when production of t-PA antigen is increased. A study of the time course of induction revealed that the synthesis of plasminogen activator occurred before that of its inhibitors. Low concentrations of PMA (0.1 ng/mL) induce t-PA antigen primarily and not the inhibitors. This results in an increase in total enzymatic activity, with 94% of the secreted activity being t-PA. Thus, the secretion of plasminogen activators and their inhibitors can be manipulated in certain leukemic cells by inducers such as PMA.

Fluid Flow Stimulates Tissue Plasminogen Activator Secretion by Cultured Human Endothelial Cells

Wall shear stress generated by blood flow may regulate the expression of fibrinolytic proteins by endothelial cells. Tissue plasminogen activator (tPA) and plasminogen activator inhibitor, type 1 (PAI-1) secretion by cultured human endothelial cells were not affected by exposure to venous shear stress (4 dynes/cm2). However, at arterial shear stresses of 15 and 25 dynes/cm2, the tPA secretion rate was 2.1 and 3.0 times greater, respectively, than the basal tPA secretion rate. PAI-1 secretion was unaffected by shear stress over the entire physiological range.

Effect of fibrinogen-clotting enzymes on secretion of plasminogen activators from cultured human endothelial cells

Fibrinogen-clotting enzymes purified from snake venoms, ancrod, batroxobin and crotalase induce a fibrinolytic state in the circulation of humans and animals. In vivo, but not in vitro, the enzymes indirectly convert fibrinogen into plasmin-derived degradation products. To explain this effect, we investigated the secretion of plasminogen activators by cultured human umbilical vein endothelial cells in response to purified snake venom enzymes. The activity of plasminogen activators was measured by a solid-phase 125I-fibrin lysis assay and the type demonstrated by fibrin zymography. Unstimulated primary or passaged cultures secreted activators at a mean rate of 0.183 or 46.6 milliunits/10 6 cells, respectively. Ancrod, batroxobin and crotalase did not affect biosynthesis and secretion of tissue plasminogen activator and did not induce pro-urokinase from primary cell cultures after 4 h. However, in passaged cells treated for 4 h, ancrod and batroxobin stimulated the secretion of plasminogen activators in a dose-dependent manner. Maximum stimulation by the two enzymes at 3 and 2 u/ml, respectively, was twofold higher than control values. In contrast, crotalase (1 u/ml), and thrombin (1 u/ml) decreased activator secretion to 32 and 11% of control values, respectively. The use of specific antibodies showed that the secreted plasminogen activators were inhibited by 90% using anti-urokinase antibodies and by 10% with anti-tissue plasminogen activator antibodies. Fibrin zymography supported the data and demonstrated that fibrinogen-clotting enzymes affected both extracellular and intracellular pro-urokinase levels. Intracellular plasminogen activators increased in cells treated with crotalase to 130% but decreased with ancrod to 40%, batroxobin to 80% and thrombin to 23%. The data indicated that the effects of the four enzymes on the secretion of plasminogen activators from passaged endothelial cells were independent of their action on fibrinogen. It is concluded that ancrod or batroxobin may activate the fibrinolytic system in vivo by stimulation of vascular endothelial cells to selectively increase pro-urokinase secretion without alteration of tissue plasminogen activator output.

Hormonal regulation of tissue plasminogen activator secretion and mRNA levels in rat granulosa cells.

Granulosa cells from immature rats produce tissue plasminogen activator (tPA) in response to follicle stimulating hormone (FSH) or luteinizing hormone (LH) both in vitro and in vivo. We have used the in vitro system to investigate the level at which the hormonal induction of tPA is regulated. Within 12 h following FSH addition, a dramatic but transient increase in tPA secretion occurs for by 24 h secretion returns to basal levels. This pattern of enzyme induction is similar with LH, but the onset of the increase is delayed. When steady-state tPA mRNA levels are examined after hormone treatment, the results mirror those obtained if one measures enzyme activity; a large increase in tPA mRNA followed by a decrease to basal levels is observed with both hormones, and the lag in induction by LH is also apparent. These results demonstrate that the regulation of tPA activity by gonadotropins occurs at the level of the steady-state concentration of the mRNA. In the presence of cycloheximide, the induction of tPA mRNA by FSH or LH is not greatly affected, indicating that this phase of the response to gonadotropins does not require the synthesis of new protein. However, the decrease in tPA mRNA levels observed 24 h after FSH treatment is affected by cycloheximide, in that the drug delays the reduction in mRNA levels seen with hormone alone.

組織性ｐｌａｓｍｉｎｏｇｅｎ ａｃｔｉｖａｔｏｒ分泌機構におよぼすｍｏｎｅｓｉｎの効果

組織性ｐｌａｓｍｉｎｏｇｅｎ ａｃｔｉｖａｔｏｒ分泌機構におよぼすｍｏｎｅｓｉｎの効果

Calcium messenger system: an integrated view.

Calcium messenger system: an integrated view.